We are live on ! Find out more
CLRB icon

Cellectar Biosciences
CLRB

44 hedge funds and large institutions have $24.2M invested in Cellectar Biosciences in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

13% more funds holding

Funds holding: 39 → 44 (+5)

0.03% less ownership

Funds ownership: 0.13% → 0.1% (-0.03%)

34% less capital invested

Capital invested by funds: $36.9M → $24.2M (-$12.7M)

Holders
44
Holders Change
+5
Holders Change %
+12.82%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
11
Reduced
6
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.28M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.23M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.22M
4
Millennium Management
Millennium Management
New York
+$452K
5
GCP
GSA Capital Partners
United Kingdom
+$310K

Top Sellers

Rank Fund Capital Flow
1
SCM
Silverarc Capital Management
Massachusetts
-$2.31M
2
6CM
683 Capital Management
New York
-$1.93M
3
ACM
Altium Capital Management
New York
-$1.77M
4
MS
Maven Securities
Jersey
-$1.63M
5
TLP
Tri Locum Partners
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFS
26
Sowell Financial Services
Arkansas
$24K +$13.7K +23 +64%
PFS
27
Prospera Financial Services
Texas
$24K +$29.1K +49 New
CAM
28
Cozad Asset Management
Illinois
$18K – – –
PAM
29
PVG Asset Management
Colorado
$16.4K +$20.2K +34 New
PNC Financial Services Group
30
PNC Financial Services Group
Pennsylvania
$16K – – –
FFA
31
First Foundation Advisors
California
$16K +$19.6K +33 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$16K +$19.6K +33 New
TCM
33
Tradewinds Capital Management
Washington
$16K +$19.6K +33 New
Osaic Holdings
34
Osaic Holdings
Arizona
$12K +$2.38K +4 +19%
Bank Julius Baer & Co
35
Bank Julius Baer & Co
Switzerland
$12K +$14.9K +25 New
HI
36
Harbour Investments
Wisconsin
$11K +$13.7K +23 New
JFGIW
37
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$7K +$8.92K +15 New
Wells Fargo
38
Wells Fargo
California
$6K – – –
US Bancorp
39
US Bancorp
Minnesota
$5K – – –
Morgan Stanley
40
Morgan Stanley
New York
$4K – – –
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$3K – – –
UBS Group
42
UBS Group
Switzerland
$3K +$1.19K +2 +40%
Barclays
43
Barclays
United Kingdom
$1K +$595 +1 New
6CM
44
683 Capital Management
New York
– -$1.93M -3,086 Closed
ACM
45
Altium Capital Management
New York
– -$1.77M -2,840 Closed
TLP
46
Tri Locum Partners
New York
– -$1.37M -2,195 Closed
SSA
47
Schonfeld Strategic Advisors
New York
– -$673K -1,080 Closed
VF
48
Virtu Financial
New York
– -$472K -756 Closed
PCM
49
Prelude Capital Management
New York
– -$271K -434 Closed
SFM
50
Sphera Funds Management
Israel
– -$182K -292 Closed
1
2
3

CLRB Hedge Fund Activity: Q1 2021 in Review

44 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q1 2021, worth a combined $24.2M — down 34% from $36.9M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CLRB positions and 11 closed out — a net gain of 5 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $1.28M. The largest seller was Silverarc Capital Management, cutting an estimated $2.31M.

  • 44 institutional investors held Cellectar Biosciences (CLRB) as of Q1 2021, up from 39 in Q4 2020.
  • Funds reported $24.2M of Cellectar Biosciences stock for Q1 2021, down 34% quarter-over-quarter.
  • 16 funds opened new Cellectar Biosciences positions in Q1 2021 and 11 closed out, a net change of +5 holders.
  • The largest Cellectar Biosciences buyer in Q1 2021 was Two Sigma Advisers, an estimated $1.28M added.
  • The largest Cellectar Biosciences seller in Q1 2021 was Silverarc Capital Management, an estimated $2.31M sold.

Based on aggregated 13F filings for Q1 2021.